Evidence map›Paper›PMID 34289805›Full record

ArticleBMC bioinformatics2021

SAUTE: sequence assembly using target enrichment.

Alexandre Souvorov, Richa Agarwala

Abstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Transition ofbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Genomic characterization of antimicrobial resistance in 61 aquatic bacterial isolates.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. In Vitro Activity of Ceftolozane-Tazobactam againstAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Characterization ofJournal of nematology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexandre SouvorovNCBI/NLM/NIH/DHHS, 8600 Rockville Pike, Bethesda, MD, 20894, USA.
Richa AgarwalaNCBI/NLM/NIH/DHHS, 8600 Rockville Pike, Bethesda, MD, 20894, USA. richa@ncbi.nlm.nih.gov.ORCID http://orcid.org/0000-0002-5518-9723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIllumina is the dominant sequencing technology at this time. Short length, short insert size, some systematic biases, and low-level carryover contamination in Illumina reads continue to make assembly of repeated regions a challenging problem. Some applications also require finding multiple well supported variants for assembled regions.

resultsTo facilitate assembly of repeat regions and to report multiple well supported variants when a user can provide target sequences to assist the assembly, we propose SAUTE and SAUTE_PROT assemblers. Both assemblers use de Bruijn graph on reads. Targets can be transcripts or proteins for RNA-seq reads and transcripts, proteins, or genomic regions for genomic reads. Target sequences are nucleotide and protein sequences for SAUTE and SAUTE_PROT, respectively.

conclusionsFor RNA-seq, comparisons with TRINITY, RNASPADES, SPALIGNER, and SPADES assembly of reads aligned to target proteins by DIAMOND show that SAUTE_PROT finds more coding sequences that translate to benchmark proteins. Using AMRFINDERPLUS calls, we find SAUTE has higher sensitivity and precision than SPADES, PLASMIDSPADES, SPALIGNER, and SPADES assembly of reads aligned to target regions by HISAT2. It also has better sensitivity than SKESA but worse precision.

Indexed as

GenomicsHigh-Throughput Nucleotide SequencingAlgorithmsGenomeRNA-SeqSequence Analysis, DNAAntimicrobial resistancede Bruijn graphsDe-novo assemblyIllumina readsRNA-seq

Identifiers

PMID34289805
PMCPMC8293564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.